Stronger together.

I am a Pediatric Hematologist Oncologist at East Carolina University, serving twenty-nine counties east of I-95. Our team provides care for children, adolescents, and young adults with cancer, sickle cell disease, and bleeding and clotting disorders, as well as patients with benign hematology, off therapy/late effects, bone marrow failure syndromes, vascular anomalies, and cancer predisposition syndromes. We participate in Children's Oncology Group (COG) clinical trials and additional clinical and pharmaceutical trials focusing on sickle cell and bleeding disorders. As a generalist, I care for all children with blood and cancer disorders and am the primary clinician for children and young adults with brain and CNS tumors. I also provide hospice care for palliative neuro-oncology patients through collaboration with local pediatric hospice entities. My clinical interests include general pediatric oncology, vascular malformations, bone marrow failure syndromes, cancer predisposition syndromes, ITP, neuro-oncology, and diagnostic dilemmas. With nearly 13 years of experience since completing fellowship, I am dedicated to providing excellent care and helping to advance the field of Pediatric Hematology/Oncology.

I am a pediatric oncologist with a MSc in clinical research. My previous research has been in leukemia/lymphoma and supportive care. I previously studied the efficacy of IVIG supplementation in preventing infection-related outcomes in children with B-ALL. My current clinical practice involves all of hematology and oncology. My research interests are in supportive care, palliative care, and collaborative efforts in treatment trials.

I am a pediatric oncologist and physician scientist focused on clinical outcomes research. I care for children with leukemia and lymphoma and also have a passion for survivorship and supporting our patients as they become young adults. My clinical research is funded through St. Baldricks and Hyundai Hope on Wheels and focuses on how social determinants of health mediate adverse outcomes for our patients upfront and in survivorship.

Dr. Hudspeth graduated as valedictorian from the MUSC College of Medicine in 1999.  She completed her pediatrics residency at Johns Hopkins Hospital and was selected as a chief resident for the Harriet Lane Service.  She completed her pediatric hematology/oncology fellowship at Johns Hopkins Hospital/National Cancer Institute.

‍

After starting her faculty career at Johns Hopkins, she returned to MUSC in 2007 with the goal of expanding the pediatric BMT program.  Her clinical research focus includes all aspects of HSCT, and she served as a protocol writer for the prospective PTCTC multi-center trial  utilizing PT-Cy for pediatric patients undergoing haploidentical BMT with myeloablative prep regimens.

‍

She is the secretary/treasurer for the American Society of Pediatric Hematology/Oncology and on the BMT-CTN Steering Committee.  She is the Medical Director for the Adult and Pediatric BMT and Cellular Therapy Program at MUSC, which was designated by CIBMTR in 2024 as an overperforming center for allogeneic transplant outcomes 2020-2022.

My primary area of clinical interest is pediatric neuro-oncology, but I take care of children with all cancers and blood disorders. I am a translational researcher and clinical trialist. My primary research interests are in better elucidating the complex mechanisms of oncogenesis, invasion, and immune escape in low and high-grade pediatric brain tumors, which together are now the leading cause of cancer-related death in children. My ultimate goal is to help develop new therapeutic strategies for pediatric brain tumors that are more effective and less toxic.

Dr. Jacqueline Kraveka is a Professor of Pediatrics and a Pediatric Hematologist-Oncologist at the Medical University of South Carolina (MUSC) in Charleston, SC. Born in Velasco, Cuba, she emigrated to the United States at age four. She earned her undergraduate degree from Columbia University in 1989 and her medical degree from Nova Southeastern University College of Osteopathic Medicine in 1994. After completing her pediatrics residency at Miami Children's Hospital in 1997, she pursued a fellowship in pediatric hematology-oncology at MUSC, where she has been on staff since 2000. Dr. Kraveka specializes in pediatric oncology, with a focus on neuroblastoma, pediatric sarcomas, precision medicine, and clinical trial development. She plays a key role in pediatric cancer research as a member of the Executive Board and Scientific Committee for the Beat Childhood Cancer Research Consortium (BCC) and serves as the Institutional Principal Investigator for Children's Oncology Group and BCC clinical trials at MUSC. Her laboratory research focuses on developing innovative therapies, including sphingolipid-mediated treatments, to improve outcomes for children with cancer.

I am a general pediatric hematologist/oncologist with experience in all types of pediatric cancer and blood diseases as well as vascular anomalies (such as hemangiomas) and histiocytosis. While I am first and foremost a clinician, I also enjoy teaching, research, and administration. My research has focused on leukemia, supportive care, fertility preservation, integrative therapies, and vascular anomalies. Outside of work, I enjoy golf, running, reading, travel, and spending time with my family.

Jennifer Pope is the Director Supportive Medicine within Levine Children's Hospital Cancer and Blood Disorders Program. In that role, she oversees and participates in the multidisciplinary teams caring for children and young adults with cancer, complex blood diseases, and cancer survivors. As an integrative medicine physician, her focus is on whole person/whole family care and support. Her research interests include integrative topics including exercise, sleep, and advanced symptom management with mind/body therapies.

I am an Assistant Professor of Pediatrics at Wake Forest University School of Medicine in the Section of Hematology Oncology. My research focuses on cancer-related financial hardship and barriers to linguistically and culturally tailored care in diverse families of children and adolescents with cancer. Through the Children's Oncology Group (COG) study ACCL20N1CD, I am currently investigating financial distress in parents of children with acute lymphoblastic leukemia (ALL) treated at COG NCI Community Oncology Research Program (NCORP) practices. I am also actively involved in multi-institutional efforts to improve cancer care delivery and access to clinical trials through the COG Cancer Care Delivery Research Committee, COG Language Equity Working Group, and the COG Diversity and Health Disparities Committee.

I direct our Isabella Santos Foundation rare and solid tumor program at Levine Children's Hospital. My area of interest is in advancing basic/translational science and early phase clinical trial opportunities for pediatric sarcoma patients.

Through my combined training in internal medicine and pediatrics, and subsequent training in pediatric hematology/oncology, I have developed both research and clinical interests in improving survivorship care and outcomes for children, adolescents, and young adults (AYAs) with cancer. As an Associate Professor of Pediatrics and the Medical Director for the Lineberger Adolescent and Young Adult (AYA) Cancer Program at the University of North Carolina at Chapel Hill, I lead clinical programs (including the UNC AYA Cancer Survivorship Clinic and the UNC Outpatient Hematology-Oncology Clinic) and initiatives to improve survivorship care and clinical research. My current work examines accelerated aging in childhood and AYA survivors. We use measures of frailty (phenotype and index), sarcopenia (bioelectrical impedance and CT scans), physical function (timed up and go, grip strength), and biological biomarkers (p16INK4a and epigenetic clocks) to describe the impact of cancer and its treatment on the aging process in survivors.

I am a pediatric oncologist at Duke, where I run our neuroblastoma, survivorship, and pediatric oncology clinical research programs.

Erin Trovillion, MD, is a Pediatric Hematologist/Oncologist. She completed her pediatric residency and fellowship training at the University of California San Diego Rady Children's Hospital, solidifying her foundation in pediatric oncology. In 2020, Dr. Trovillion joined the Levine Children's Pediatric Cancer and Blood Disorders team specializing in sarcoma as part of the Isabella Santos Foundation Rare and Solid Tumor Program. Driven by a passion for enhancing patient care, Dr. Trovillion spearheaded the creation of the Pediatric Oncofertility Team, which has evolved into a multidisciplinary program offering consultations to pediatric oncology patients of all ages undergoing gonadotoxic treatments. Her commitment to comprehensive care now extends to her role as the Medical Director of the Adolescent and Young Adult (AYA) comprehensive program at Atrium Health Levine Cancer, reshaping cancer care for adolescents and young adults by working collaboratively to leverage resources and expertise across the enterprise to improve patient outcomes. In addition to her clinical duties, Dr. Trovillion is an active member of the Pediatric Hematology/Oncology Blood Quality Improvement Committee and the Best Practice Committee striving to elevate standards of care for all patients.

Personally, I am a wife to a fearless stay-at-home dad and a mother to 5 amazing children. Professionally, I am a general pediatric hematologist/oncologist, but my focus is on pediatric oncology. I am the local PI for COG and the director of the oncology survivorship clinic. My patients deserve the best care possible. My job is to give them my all and never give up. I gain inspiration and hope in return.

Dr. Blanco has dedicated her career to understanding and treating medulloblastoma, the most common malignant brain tumor in children. She earned her PhD in Neurosciences at the University of Oviedo (Spain) and pursued further training at Columbia University and the University of Miami, specializing in developmental signaling and cancer. During her second postdoctoral fellowship, she combined neuroscience and cancer signaling to investigate pediatric brain tumors.Now an independent investigator at the NCI-designated Hollings Cancer Center and the Darby Children's Research Institute at MUSC, Dr. Blanco focuses on medulloblastoma relapse and metastatic disease. Her studies include recent publications in Science Advances and Journal of Clinical Investigation as a corresponding author. She has received prestigious awards, including the Alex's Lemonade Stand Foundation "A" Award, the V Foundation Scholar Award, a Rally Foundation Career Development Award, and an NINDS K01 Award. Committed to translating research into actionable treatments, she strives to improve outcomes for children with brain tumors.

I received my doctoral degree from Florida International University in Miami, FL and was an American Cancer Society postdoctoral fellow at Duke University. I am currently an Assistant Professor in the Department of Medicine at Duke University. I serve as the Director of Research for the Duke Cancer Institute Comparative Oncology Group and as Director of the Duke University Marine Laboratory Scholars in Marine Medicine Program. Our research team uses evolutionary and ecology paradigms to understand molecular adaptations to extreme environments. Our work spans diverse topics, such as the evolutionary pressures faced by cancer cells during drug treatment and metastatic spread, the molecular adaptations of whales and other marine mammals to low oxygen conditions, and the evolution of microbes to use plastic as a nutrient source. In addition to my scholarly activities, I am passionately involved in training and education, leading multiple outreach and research training programs for high school students and undergraduates in an effort to enhance opportunities in STEM careers.